查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825733

2025年全球臉部注射劑市場報告

Facial Injectable Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年臉部注射劑市場將強勁成長，到2029年將達到217.8億美元，年複合成長率（CAGR）為9.6%。預測期內的成長可歸因於非手術治療需求的持續成長、應用領域的拓展、個人化和客製化、新興市場、醫療保健趨勢以及生活方式的改變。預測期內的主要趨勢包括：非手術治療需求的持續成長、個人化治療方法的擴展、對聯合治療以提升治療效果的日益重視、微創技術和設備的興起，以及對自然、細微效果的追求。

未來五年的預測成長率為9.6%，較我們先前對該市場的預測略有下降0.9%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會增加來自瑞典和法國的透明質酸填充劑和肉毒桿菌素製劑的成本，從而擾亂美國的美容和治療業務。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，關稅的影響可能更為廣泛。

預計未來幾年，人們對美容手術日益成長的興趣將推動臉部注射劑市場的成長。美容手術包括旨在改善外觀同時最大程度地減少對身體自然結構的破壞的治療。它們通常比傳統手術侵入性更小，並且通常在門診病人進行。社會對外觀的關注、醫學進步帶來的更安全、更方便的手術，以及人們對自我提升和增強自信日益成長的渴望，推動了對此類手術的需求。臉部注射劑用於美容手術，透過精確注射肉毒桿菌毒素和真皮填充劑等物質，可以暫時減少皺紋、增加特定部位的豐盈度並改善臉部輪廓。例如，根據英國美容整形外科醫師協會 2023 年 3 月的報告，2022 年英國的美容手術數量與 2021 年相比增加了 102%，達到約 31,057 例。因此，對美容手術日益成長的需求推動了臉部注射劑市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球臉部注射：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球臉部注射劑市場：成長率分析
  • 全球臉部注射劑市場表現：規模與成長，2019-2024
  • 全球臉部注射劑市場預測：規模與成長，2024-2029年，2034年
  • 全球臉部注射劑：總目標市場（TAM）

第6章 市場細分

  • 全球臉部注射劑市場：按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 肉毒桿菌毒素
  • 膠原蛋白
  • 玻尿酸
  • 羥基磷灰石鈣
  • 聚乳酸
  • 聚甲基丙烯酸甲酯微球（PMMA）
  • 脂肪注射
  • 其他類型
  • 全球臉部注射劑市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 減少皺紋
  • 拉皮
  • 痤瘡疤痕治療
  • 脂肪營養障礙的治療
  • 豐唇
  • 其他用途
  • 全球臉部注射劑市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院及門診手術中心
  • 皮膚科和美容診所
  • 其他最終用戶
  • 全球臉部注射市場：按肉毒桿菌類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • A 型肉毒桿菌（Botox、 Dysport、 Xeomin）
  • B型肉毒桿菌毒素（Myoblock、Neuroblock）
  • 全球臉部注射劑市場：膠原蛋白蛋白（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 牛膠原蛋白
  • 人體膠原蛋白
  • 合成膠原膠原蛋白
  • 全球臉部注射劑市場：依透明質酸（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 交聯玻尿酸
  • 非交聯玻尿酸
  • 全球臉部注射劑市場：依羥基磷灰石鈣（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • Radius（羥基磷灰石鈣基填料）
  • 全球臉部注射劑市場：聚乳酸細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • Sculptra（聚乳酸填充劑）
  • 全球臉部注射劑市場：按聚甲基丙烯酸甲酯微球（PMMA）細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • Artefill（PMMA基填充劑）
  • 全球臉部注射劑市場：細分市場、脂肪注射類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 自體脂肪移植（抽脂和注射）
  • 脂肪移植恢復體積
  • 全球臉部注射劑市場：按類型、其他、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 聚左旋乳酸
  • 聚己內酯填料
  • 其他新興注射劑

第7章 區域和國家分析

  • 全球臉部注射劑市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球臉部注射劑市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 臉部注射劑市場：競爭格局
  • 臉部注射劑市場：公司簡介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
    • Galderma SA Overview, Products and Services, Strategy and Financial Analysis
    • Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Sinclair Pharma Plc
  • Revance Therapeutics Inc.
  • Suneva Medical Inc.
  • Prollenium Medical Technologies
  • SciVision Biotech Inc.
  • Anteis SA
  • Anika Therapeutics Inc.
  • Q-Med AB
  • Bloomage BioTechnology
  • Medytox Inc.
  • Teoxane Laboratories
  • Alphaeon Corporation
  • BIOPLUS CO. LTD.
  • BioPolymer GmbH & Co. KG
  • Bioxis Pharmaceuticals

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年臉部注射劑市場：提供新機會的國家
  • 2029年臉部注射劑市場：細分領域帶來新機會
  • 2029年臉部注射劑市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r30186u

Facial injectables are cosmetic procedures that involve injecting substances into facial tissues to enhance features, diminish wrinkles, restore volume, or enhance overall appearance without surgery. These treatments are commonly used to address aging signs or achieve specific aesthetic goals, offering results that are temporary or semi-permanent.

The primary types of facial injectables include botulinum toxin, collagen, hyaluronic acid, calcium hydroxyapatite, polylactic acid, polymethyl-methacrylate microspheres (PMMA), fat injection, and others. Botulinum toxin is a neurotoxic protein used in cosmetic procedures to temporarily relax muscle activity, primarily for reducing facial wrinkles and lines. These injectables serve various purposes such as wrinkle reduction, facelifts, acne scar treatment, lipoatrophy treatment, lip enhancement, and more. They are used by different end-users including hospitals, ambulatory surgery centers, dermatology and cosmetic clinics, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The facial injectable market research report is one of a series of new reports from The Business Research Company that provides facial injectable market statistics, including facial injectable industry global market size, regional shares, competitors with a facial injectable market share, detailed facial injectable market segments, market trends and opportunities, and any further data you may need to thrive in the facial injectable industry. This facial injectable market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The facial injectable market size has grown strongly in recent years. It will grow from $13.74 billion in 2024 to $15.11 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the increased aging population, growth in consumer awareness, shift in beauty standards, regulatory approvals, and advancements in injection techniques.

The facial injectable market size is expected to see strong growth in the next few years. It will grow to $21.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising demand for non-surgical procedures, expanding applications, personalization and customization, emerging markets, healthcare trends, and lifestyle changes. Major trends in the forecast period include continued growth in demand for non-surgical procedures, expansion of personalized treatment approaches, increasing focus on combination therapies for enhanced outcomes, the rise of minimally invasive techniques and devices, and a shift towards natural-looking and subtle results.

The forecast of 9.6% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. cosmetic and therapeutic procedures by increasing costs for hyaluronic acid fillers and botulinum toxin products sourced from Sweden and France, potentially reducing patient affordability and raising dermatology practice expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising interest in cosmetic procedures is expected to drive the growth of the facial injectable market in the coming years. Cosmetic procedures encompass medical treatments aimed at enhancing appearance with minimal disruption to the body's natural structure, often less invasive than traditional surgeries and typically performed on an outpatient basis. This demand is increasing due to societal focus on appearance, safer and more accessible procedures enabled by medical advancements, and a growing desire for self-improvement and confidence boost. Facial injectables are used in cosmetic procedures to temporarily reduce wrinkles, add volume to specific areas, and improve facial contours through precise injection of substances such as botulinum toxin or dermal fillers. For example, in March 2023, a report from the British Association of Aesthetic Plastic Surgeons noted a 102% increase in cosmetic procedures in the UK in 2022, reaching around 31,057 procedures, compared to 2021. Thus, the rising demand for cosmetic procedures is fueling the growth of the facial injectable market.

Leading companies in the facial injectable market are innovating with products such as long-lasting hyaluronic acid (HA) fillers to meet the demand for minimally invasive aesthetic procedures offering natural-looking and enduring results. HA fillers restore volume, smooth wrinkles, and enhance facial contours by replenishing natural skin substances. For instance, in January 2023, Allergan plc introduced JUVEDERM VOLUX XC, an HA filler specifically designed to enhance jawline definition for individuals aged 21 and above with moderate to severe contour loss. Providing effects lasting up to twelve months, JUVEDERM VOLUX XC delivers natural-looking results with minimal downtime, appealing to patients seeking non-surgical options. Supported by research and high patient satisfaction, this filler enables customized treatment plans by cosmetic specialists.

In October 2022, Prollenium Medical Technologies acquired SoftFil for an undisclosed amount, expanding its product range and enhancing its position in the aesthetic medicine industry. This acquisition strengthens innovation and offers comprehensive solutions to practitioners for optimal patient outcomes. SoftFil, a France-based company, produces cosmetic products, aesthetic microcannulas, and facial injectable solutions, complementing Prollenium's portfolio.

Major companies operating in the facial injectable market are AbbVie Inc., Sanofi S.A., Ipsen Pharma, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Sinclair Pharma Plc, Revance Therapeutics Inc., Suneva Medical Inc., Prollenium Medical Technologies, SciVision Biotech Inc., Anteis S.A., Anika Therapeutics Inc., Q-Med AB, Bloomage BioTechnology, Medytox Inc., Teoxane Laboratories, Alphaeon Corporation, BIOPLUS CO. LTD., BioPolymer GmbH & Co. KG, Bioxis Pharmaceuticals, Everest Pharmaceuticals

North America was the largest region in the facial injectable market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facial injectable market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the facial injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facial injectable market consists of sales of platelet-rich plasma (PRP) injections, collagen stimulators, lip injections, and thread lifts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facial Injectable Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on facial injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facial injectable ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The facial injectable market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Botulinum Toxin; Collagen; Hyaluronic Acid; Calcium Hydroxyapatite; Polylactic Acid; Polymethyl-Methacrylate Microspheres (PMMA); Fat Injection; Other Types
  • 2) By Application: Wrinkle Reduction; Facelift; Acne Scar Treatment; Lipoatrophy Treatment; Lip Enhancement; Other Applications
  • 3) By End-User: Hospitals And Ambulatory Surgery Centers; Dermatology And Cosmetic Clinics; Other End-Users
  • Subsegments:
  • 1) By Botulinum Toxin: Botulinum Toxin Type A (Botox, Dysport, Xeomin); Botulinum Toxin Type B (Myobloc, Neurobloc)
  • 2) By Collagen: Bovine Collagen; Human Collagen; Synthetic Collagen
  • 3) By Hyaluronic Acid: Cross-linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
  • 4) By Calcium Hydroxyapatite: Radiesse (Calcium Hydroxyapatite-Based Fillers)
  • 5) By Polylactic Acid: Sculptra (Polylactic Acid-Based Fillers)
  • 6) By Polymethyl Methacrylate Microspheres (PMMA): Artefill (PMMA-Based Fillers)
  • 7) By Fat Injection: Autologous Fat Transfer (Liposuction And Injection); Fat Grafting For Volume Restoration
  • 8) By Other Types: Poly-L-Lactic Acid; Polycaprolactone-Based Fillers; Other Emerging Injectable Fillers
  • Companies Mentioned: AbbVie Inc.; Sanofi S.A.; Ipsen Pharma; Galderma S.A.; Merz Pharma GmbH & Co. KGaA; Sinclair Pharma Plc; Revance Therapeutics Inc.; Suneva Medical Inc.; Prollenium Medical Technologies; SciVision Biotech Inc.; Anteis S.A.; Anika Therapeutics Inc.; Q-Med AB; Bloomage BioTechnology; Medytox Inc.; Teoxane Laboratories; Alphaeon Corporation; BIOPLUS CO. LTD.; BioPolymer GmbH & Co. KG; Bioxis Pharmaceuticals; Everest Pharmaceuticals
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Facial Injectable Market Characteristics

3. Facial Injectable Market Trends And Strategies

4. Facial Injectable Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Facial Injectable Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Facial Injectable PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Facial Injectable Market Growth Rate Analysis
  • 5.4. Global Facial Injectable Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Facial Injectable Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Facial Injectable Total Addressable Market (TAM)

6. Facial Injectable Market Segmentation

  • 6.1. Global Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulinum Toxin
  • Collagen
  • Hyaluronic Acid
  • Calcium Hydroxyapatite
  • Polylactic Acid
  • Polymethyl-Methacrylate Microspheres (PMMA)
  • Fat Injection
  • Other Types
  • 6.2. Global Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wrinkle Reduction
  • Facelift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Lip Enhancement
  • Other Applications
  • 6.3. Global Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgery Centers
  • Dermatology And Cosmetic Clinics
  • Other End-Users
  • 6.4. Global Facial Injectable Market, Sub-Segmentation Of Botulinum Toxin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulinum Toxin Type A (Botox, Dysport, Xeomin)
  • Botulinum Toxin Type B (Myobloc, Neurobloc)
  • 6.5. Global Facial Injectable Market, Sub-Segmentation Of Collagen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Collagen
  • Human Collagen
  • Synthetic Collagen
  • 6.6. Global Facial Injectable Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cross-linked Hyaluronic Acid
  • Non-Cross-Linked Hyaluronic Acid
  • 6.7. Global Facial Injectable Market, Sub-Segmentation Of Calcium Hydroxyapatite, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiesse (Calcium Hydroxyapatite-Based Fillers)
  • 6.8. Global Facial Injectable Market, Sub-Segmentation Of Polylactic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sculptra (Polylactic Acid-Based Fillers)
  • 6.9. Global Facial Injectable Market, Sub-Segmentation Of Polymethyl Methacrylate Microspheres (PMMA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artefill (PMMA-Based Fillers)
  • 6.10. Global Facial Injectable Market, Sub-Segmentation Of Fat Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autologous Fat Transfer (Liposuction And Injection)
  • Fat Grafting For Volume Restoration
  • 6.11. Global Facial Injectable Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Poly-L-Lactic Acid
  • Polycaprolactone-Based Fillers
  • Other Emerging Injectable Fillers

7. Facial Injectable Market Regional And Country Analysis

  • 7.1. Global Facial Injectable Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Facial Injectable Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Facial Injectable Market

  • 8.1. Asia-Pacific Facial Injectable Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Facial Injectable Market

  • 9.1. China Facial Injectable Market Overview
  • 9.2. China Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Facial Injectable Market

  • 10.1. India Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Facial Injectable Market

  • 11.1. Japan Facial Injectable Market Overview
  • 11.2. Japan Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Facial Injectable Market

  • 12.1. Australia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Facial Injectable Market

  • 13.1. Indonesia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Facial Injectable Market

  • 14.1. South Korea Facial Injectable Market Overview
  • 14.2. South Korea Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Facial Injectable Market

  • 15.1. Western Europe Facial Injectable Market Overview
  • 15.2. Western Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Facial Injectable Market

  • 16.1. UK Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Facial Injectable Market

  • 17.1. Germany Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Facial Injectable Market

  • 18.1. France Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Facial Injectable Market

  • 19.1. Italy Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Facial Injectable Market

  • 20.1. Spain Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Facial Injectable Market

  • 21.1. Eastern Europe Facial Injectable Market Overview
  • 21.2. Eastern Europe Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Facial Injectable Market

  • 22.1. Russia Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Facial Injectable Market

  • 23.1. North America Facial Injectable Market Overview
  • 23.2. North America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Facial Injectable Market

  • 24.1. USA Facial Injectable Market Overview
  • 24.2. USA Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Facial Injectable Market

  • 25.1. Canada Facial Injectable Market Overview
  • 25.2. Canada Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Facial Injectable Market

  • 26.1. South America Facial Injectable Market Overview
  • 26.2. South America Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Facial Injectable Market

  • 27.1. Brazil Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Facial Injectable Market

  • 28.1. Middle East Facial Injectable Market Overview
  • 28.2. Middle East Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Facial Injectable Market

  • 29.1. Africa Facial Injectable Market Overview
  • 29.2. Africa Facial Injectable Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Facial Injectable Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Facial Injectable Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Facial Injectable Market Competitive Landscape And Company Profiles

  • 30.1. Facial Injectable Market Competitive Landscape
  • 30.2. Facial Injectable Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Ipsen Pharma Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Galderma S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merz Pharma GmbH & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Facial Injectable Market Other Major And Innovative Companies

  • 31.1. Sinclair Pharma Plc
  • 31.2. Revance Therapeutics Inc.
  • 31.3. Suneva Medical Inc.
  • 31.4. Prollenium Medical Technologies
  • 31.5. SciVision Biotech Inc.
  • 31.6. Anteis S.A.
  • 31.7. Anika Therapeutics Inc.
  • 31.8. Q-Med AB
  • 31.9. Bloomage BioTechnology
  • 31.10. Medytox Inc.
  • 31.11. Teoxane Laboratories
  • 31.12. Alphaeon Corporation
  • 31.13. BIOPLUS CO. LTD.
  • 31.14. BioPolymer GmbH & Co. KG
  • 31.15. Bioxis Pharmaceuticals

32. Global Facial Injectable Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Facial Injectable Market

34. Recent Developments In The Facial Injectable Market

35. Facial Injectable Market High Potential Countries, Segments and Strategies

  • 35.1 Facial Injectable Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Facial Injectable Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Facial Injectable Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer